Authors: Wahlbeck, K Cheine, M Tuisku, K Ahokas, A Joffe, G Rimon, R

Citation: K. Wahlbeck et al., Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study, PROG NEUR-P, 24(6), 2000, pp. 911-922

Authors: Joffe, G Nyberg, P Gross, A Appelberg, B

Citation: G. Joffe et al., Is there an association between the effects of clozapine on the productionof reactive oxygen metabolites by blood monocytes and clinical outcome in neuroleptic-resistant schizophrenia? (vol 13, pg 231, 1998), HUM PSYCHOP, 14(4), 1999, pp. 282-282

Authors: Joffe, G Nyberg, P Gross, A Appelberg, B

Citation: G. Joffe et al., Clozapine-induced decrease in the production of reactive oxygen metabolites by monocytes in vitro may predict clinical response to clozapine in treatment-resistant schizophrenia, HUM PSYCHOP, 14(3), 1999, pp. 203-209

Authors: Joffe, G Appelberg, B Rimon, R

Citation: G. Joffe et al., Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study, INT CLIN PS, 14(4), 1999, pp. 233-238

Authors: Joffe, G

Citation: G. Joffe, At the turning point, WORLD TODAY, 55(4), 1999, pp. 11-13